Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors

NCT00497081 is registered in ClinicalTrials.gov with San Francisco Department of Public Health as lead sponsor.

NCT NCT00497081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00497081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
Lead sponsor
San Francisco Department of Public Health
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2007
Completion date
March 31, 2010
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, substance abuse